C6 NBD Galactosylceramide (d18:1/6:0), CAS 170212-26-7

Formulation: A solid

Formal Name: N-[(1S,2R,3E)-1-[(β-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-hexanamide

Purity: ≥98%

Formula Markup: C36H59N5O11

Formula Weight: 737,9

Shelf life (days): 1460

CAS Number: 170212-26-7

Notes: C6 NBD galactosylceramide is a biologically active derivative of galactosylceramide that is tagged with a fluorescent C6 nitrobenzoxadiazole (C6 NBD; Item No. 18871) group.{37105} C6 NBD galactosylceramide has been used to study intracellular localization and metabolism of galactosylceramide, a sphingolipid whose synthesis is disrupted in Krabbe disease due to a deficiency of galactosylceramide β-galactosidase.{37105,37104,37106} As this product is derived from a natural source, there may be variations in the sphingoid backbone. [Matreya, LLC. Catalog No. 1621]

• Artikelnummer: CAY22830
• Hersteller: Cayman Chemical
• Hersteller Artikelnummer: 22830-100
• Green Labware: Nein
• Verpackungseinheit: 100 µg
• Mengeneinheit: STK
• Methode: Fluorescence